Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D F Nixon

Showing results (51-60 of 59) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 59 results.
The Journal of Infectious Diseases|August 19, 2000
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruptionE Papasavvas, G M Ortiz, R Gross, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2015
Antiviral gene expression in psoriasisR A Raposo, R Gupta, M Abdel-Mohsen, et al.
The Journal of Experimental Medicine|July 6, 2000
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic functionV Appay, D F Nixon, S M Donahoe, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
Clinical and Experimental Immunology|September 26, 2009
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseL C Ndhlovu, J E Snyder-Cappione, K I Carvalho, et al.
The Journal of Infectious Diseases|February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responsesM Markowitz, M Vesanen, K Tenner-Racz, et al.
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Pageof 6

Showing results (51-60 of 59) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 59 results.
The Journal of Infectious Diseases|August 19, 2000
Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruptionE Papasavvas, G M Ortiz, R Gross, et al.
Journal of Virology|December 16, 1998
Decay kinetics of human immunodeficiency virus-specific effector cytotoxic T lymphocytes after combination antiretroviral therapyG S Ogg, X Jin, S Bonhoeffer, et al.
Science (New York, N.Y.)|April 16, 1998
Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNAG S Ogg, X Jin, S Bonhoeffer, et al.
Journal of the European Academy of Dermatology and Venereology : JEADV|March 27, 2015
Antiviral gene expression in psoriasisR A Raposo, R Gupta, M Abdel-Mohsen, et al.
The Journal of Experimental Medicine|July 6, 2000
HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic functionV Appay, D F Nixon, S M Donahoe, et al.
The Journal of Infectious Diseases|December 23, 1999
High frequency of cytomegalovirus-specific cytotoxic T-effector cells in HLA-A*0201-positive subjects during multiple viral coinfectionsX Jin, M A Demoitie, S M Donahoe, et al.
Clinical and Experimental Immunology|September 26, 2009
Lower numbers of circulating Natural Killer T (NK T) cells in individuals with human T lymphotropic virus type 1 (HTLV-1) associated neurological diseaseL C Ndhlovu, J E Snyder-Cappione, K I Carvalho, et al.
The Journal of Infectious Diseases|February 10, 1999
The effect of commencing combination antiretroviral therapy soon after human immunodeficiency virus type 1 infection on viral replication and antiviral immune responsesM Markowitz, M Vesanen, K Tenner-Racz, et al.
The Journal of Clinical Investigation|September 24, 1999
HIV-1-specific immune responses in subjects who temporarily contain virus replication after discontinuation of highly active antiretroviral therapyG M Ortiz, D F Nixon, A Trkola, et al.
Pageof 6